Delivery Order SPE2DB22D3501-SPE2DB23FXG31
Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $149
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $31,000 to Amerisourcebergen Drug Corporation for the supply of docetaxel, an oncology drug. The delivery order was issued under an existing prime vendor contract held by Amerisourcebergen Corporation to provide pharmaceutical products and services to military treatment facilities for the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $54,620 to Amerisourcebergen Drug Corporation to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel. The single day order is to be fulfilled on August 1-2, 2023 with performance taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned through its prime...
- The Defense Logistics Agency awarded a $478,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 mg/16 ml vials of docetaxel. The single order is for an unspecified quantity of the chemotherapy drug to be delivered to a Conshohocken, Pennsylvania facility between July 14-17, 2023. Amerisourcebergen will serve as the prime contractor, with no mention of major subcontractors. The DLA manages the Department of Defense's global logistics operations,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately thirty-nine thousand dollars to Amerisourcebergen Drug Corporation for docetaxel, an oncology drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in September 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for docetaxel is consistent with DLA's role in supporting the military health system and...
- The Defense Logistics Agency awarded a $478,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 160 mg/16 ml vials of docetaxel. The single order is for the chemotherapy drug to be delivered to a facility in Conshohocken, Pennsylvania by August 17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and likely issued this delivery order to fulfill chemotherapy requirements for military...
- Defense Logistics Agency awarded a $466 firm fixed price delivery order to Amerisourcebergen Drug Corp for docetaxel 80 mg/4 ml vials. The delivery order was issued against an existing vehicle and requires Amerisourcebergen to provide four hundred sixty-six dollars' worth of the chemotherapy drug to the agency by October 18, 2023. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical...
- The Defense Logistics Agency awarded a $573.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562330781, described as 160 mg/16 ml vials of docetaxel in 16 ml quantities. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 27-28, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military services and combatant commands worldwide. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $54,620 to Amerisourcebergen Drug Corporation for the supply of 4561663478, described as DOCETAXEL 160 MG/8 ML VIAL 8ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between August 1-2, 2023. No subcontractors or set aside designations were identified. This order is likely...
- The Defense Logistics Agency awarded a $38,950 delivery order to Amerisourcebergen Drug Corporation for the provision of 4562215102 DOCETAXEL 80 MG/4 ML VIAL 4ML pharmaceutical products. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide chemotherapy drugs in support of DLA and Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from...
- <p>Defense Logistics Agency awarded a $157 firm fixed price delivery order to Amerisourcebergen Drug Corp for the product "DOCETAXEL 20 MG/ML VIALML." Performance will occur in Conshohocken, Pennsylvania. No set-aside provisions were specified. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is likely associated with DLA's mission to provide pharmaceuticals and other medical commodities to the Department of Defense.</p>
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXG31Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $149,340 to Amerisourcebergen Drug Corporation to supply docetaxel, an oncology drug, for one day's performance in Conshohocken, Pennsylvania. As a prime contractor on the Defense Logistics Agency's Prime Vendor program, which covers pharmaceuticals and other medical commodities for the Department of Defense, Amerisourcebergen will deliver the chemotherapy medication from its distribution center to support DOD oncology treatment programs. No subcontractors or set aside designations were indicated in the award information.
Generated 12/19/23, 2:01 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $149 | 9/19/23 |